Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study

Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study

<p>Abstract</p> <p>Background</p> <p>Treatment options for patients suffering from progressive forms of multiple sclerosis (MS) remain inadequate. Mast cells actively participate in the pathogenesis of MS, in part because they release large amounts of various mediators...

Full description

Bibliographic Details
Main Authors: Vermersch Patrick, Benrabah Rabah, Schmidt Nicolas, Zéphir Hélène, Clavelou Pierre, Vongsouthi Cyrille, Dubreuil Patrice, Moussy Alain, Hermine Olivier
Format: Article
Language:English
Published: BMC 2012-06-01
Series:BMC Neurology
Subjects:
Multiple sclerosis
Primary progressive multiple sclerosis
Secondary progressive multiple sclerosis
Tyrosine kinase inhibitor
Masitinib
Mast cells
Online Access:http://www.biomedcentral.com/1471-2377/12/36

Internet

http://www.biomedcentral.com/1471-2377/12/36

Similar Items